Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
04/25/1989 | CA1253156A1 2h-azeto¬2,1-a|-isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them |
04/25/1989 | CA1253155A1 Hexahydropyrrolo ¬2,1-a| isoquinoline derivatives |
04/25/1989 | CA1253154A1 Benzo¬ij|quinolizine-2-carboxylic acid derivatives |
04/25/1989 | CA1253148A1 1-piperazinecarboxamide derivatives |
04/25/1989 | CA1253147A1 3-acylamino-1-sulfonylaminocarbonylmethoxy-2- azetidinones |
04/25/1989 | CA1253141A1 16-keto-17-substituted thia-17-alkyl (or alkenyl or alkynyl) androstenes |
04/25/1989 | CA1253099A1 Difficol, intermediate in antibiotic preparation |
04/25/1989 | CA1253097A1 Antibiotic x-14934a |
04/25/1989 | CA1253079A1 Process for preparation of a solid form for oral use based on nifedipine with controlled release of the active substance |
04/25/1989 | CA1253078A1 Injection solution containing choline theophyllinate |
04/25/1989 | CA1253077A1 Easily dispersible agglomerated hygroscopic compositions and methods for enhancing dispersibility of agglomerated hygroscopic compositions |
04/25/1989 | CA1253076A1 Peritoneal dialysis and compositions for use therein |
04/25/1989 | CA1253073A1 Antigenic preparations and isolation of such preparations |
04/20/1989 | WO1989003399A1 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
04/20/1989 | WO1989003390A1 Soft steroids having anti-inflammatory activity |
04/20/1989 | WO1989003389A1 Lipophilic salts of s-adenosyl-l-methionine (sam) with acylated taurine derivatives |
04/20/1989 | WO1989003384A1 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
04/20/1989 | WO1989003376A1 Keratosis-treating agent |
04/20/1989 | WO1989003224A1 Product containing as active principles: a) a peptide having an activity of the type of that of human gamma interferon, b) hydroxyurea |
04/20/1989 | WO1989003220A1 Phosphatidyl treatment of viral disease |
04/20/1989 | WO1989003219A1 Improved method for treatment of gastrointestinal disorders |
04/20/1989 | WO1989003218A1 Method for inhibiting the growth of salmonella |
04/20/1989 | WO1989003217A1 ANTIVIRAL APPLICATION OF alpha OLIGONUCLEOTIDES |
04/20/1989 | WO1989003216A1 Use of 5-aminosalicyclic acid (5-asa) for the production of a pharmaceutical preparation for use in reperfusion treatment |
04/20/1989 | WO1989003215A1 Use of oxoquinazoline derivatives for the treatment of hyperlipidemia |
04/20/1989 | WO1989003214A1 Method to prevent neonatal jaundice |
04/20/1989 | WO1989003213A1 Mixture of substances for stabilyzing metabolism |
04/20/1989 | WO1989003212A1 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents |
04/20/1989 | WO1989003211A1 Treatment of cocaine addiction |
04/20/1989 | WO1989003210A1 Liquid ibuprofen compositions and methods of making them |
04/20/1989 | WO1989003209A1 Contraceptive composition comprising nonoxynol-9, and d-propranolol or a pharmaceutically acceptable salt thereof |
04/20/1989 | WO1989003208A1 Polyene macrolide pre-liposomal powders |
04/20/1989 | WO1989003205A1 Viscoelastic material for ophthalmic surgery |
04/19/1989 | EP0312432A1 2,2-Dimethyl chromene derivatives, preparation process and pharmaceutical compositions containing them |
04/19/1989 | EP0312423A2 Antiparasitic agents, processes for their production, and antiparasitic compositions, especially antimalerials containing these agents |
04/19/1989 | EP0312412A1 Norbornane derivatives, method for their preparation and cosmetic and medicinal compositions containing them |
04/19/1989 | EP0312345A2 1-(5-(4-substituted-1-piperazinyl)methyl)-pyrrol-2-yl or furan-2-yl)methyl-2-piperidinones useful in treating schizophrenia |
04/19/1989 | EP0312340A1 Use of carbomer in controlled-release formulations to enhance or increase the dissolution rate of poorly soluble pharmacologically active substances |
04/19/1989 | EP0312338A1 Sulfamoyl-2-benzofurancarboxylic acid derivatives, their preparation and use |
04/19/1989 | EP0312269A2 3,5-Dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents |
04/19/1989 | EP0312265A2 Adhesive compositions, controlled release compositions and transdermal drug delivery device |
04/19/1989 | EP0312245A2 Polycyclic compounds and pharmaceutical compositions thereof |
04/19/1989 | EP0312234A2 Shampoo compositions |
04/19/1989 | EP0312222A1 Treatment of diseases caused by viruses |
04/19/1989 | EP0312189A1 10-Propyl-2,8-bis(1H-tetrazol-5-yl)-4H,6H-benzo(1,2-b;5,4-b')dipyran-4,6-dione calcium salt |
04/19/1989 | EP0312132A2 Veterinary and human medical remedy having an antiviral and antitumorous activity, containing 2,6-diamino-3-phenyl-azo-pyridine |
04/19/1989 | EP0312086A2 Polysulfuric esters of amides of bis-aldonic acids and their derivatives, a method for their preparation and a drug |
04/19/1989 | EP0312085A2 Novel quinoline derivatives, processes for preparation thereof and antibacterial agent containing them |
04/19/1989 | EP0312076A1 Use of oxoquinazoline derivatives in the treatment of hyperlipidemia |
04/19/1989 | EP0312055A2 6-Fluoroprostaglandins |
04/19/1989 | EP0312041A2 2,4-Disubstituted 1,3-dioxolanes |
04/19/1989 | EP0312040A2 2,4-Disubstituted derivatives of tetrahydrofuran |
04/19/1989 | EP0312000A1 Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents |
04/19/1989 | EP0311955A2 Bicyclic peroxide |
04/19/1989 | EP0311866A1 Treatment of lipoprotein anomalies linked to cholesterol metabolism |
04/19/1989 | EP0311724A1 Anxiolytic-R-N-(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides |
04/19/1989 | EP0311651A1 Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs |
04/19/1989 | EP0311634A1 6-(6-alkylpyridone)-carbostyril compounds and their cardiotonic uses |
04/19/1989 | EP0201571B1 Pharmaceutical composition, its production and use |
04/19/1989 | EP0193013B1 Benzimidazolyl-pyridazinones |
04/19/1989 | CN1032443A Method for preparing phospinic acids used in preparing ace inhibitors and intermediates produced thereby |
04/19/1989 | CN1032442A Monohydrate and solvates of b-lactam antibiotic |
04/19/1989 | CN1032440A 4-aminopyridine derivatives |
04/19/1989 | CN1032439A Process for preparation of platelet activating factor antagonist |
04/19/1989 | CN1032438A Substituted n-(-alkyl-3-hydroxy-4-piperidinyl) benzamides |
04/19/1989 | CN1032437A Immunomodulatory azaspiranes |
04/18/1989 | US4822999 Apparatus and method for detecting movement of an object |
04/18/1989 | US4822895 3-aminoazetidine, its salts and intermediates of synthesis |
04/18/1989 | US4822888 New cepham compounds and processes for the production thereof |
04/18/1989 | US4822881 Psychotic disorders, anxiety, nausea, vomiting |
04/18/1989 | US4822879 Lower toxicity than griseolic acid itself |
04/18/1989 | US4822877 Modified haem |
04/18/1989 | US4822823 Improved water solubility by adding cyclodextrin derivatives |
04/18/1989 | US4822822 Benzylamine derivatives, and use thereof |
04/18/1989 | US4822821 A-amino-or butryic acid, isomers, and/or insulin |
04/18/1989 | US4822820 Applying prostaglandins; reduced side effects |
04/18/1989 | US4822819 Use of trimoprostil and derivatives in glaucoma therapy |
04/18/1989 | US4822817 Remedy for bone disease |
04/18/1989 | US4822816 Aldonolactone or salt of threonic, xylonic or lyxonic acid |
04/18/1989 | US4822815 Dioxane hexenoic acids |
04/18/1989 | US4822814 Preventing or treating liver disorders; fungicides; or preventing accumulation of fat |
04/18/1989 | US4822813 3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins, and treatment of leukemia and tumors therewith |
04/18/1989 | US4822812 Antidepressant-monoamine oxidase inhibitor |
04/18/1989 | US4822811 Carbazole lipoxygenase inhibiting compounds, compositions and use |
04/18/1989 | US4822808 Method for production of stable nicorandil preparation |
04/18/1989 | US4822807 Pharmaceutical composition containing a stable modification of torasemide |
04/18/1989 | US4822804 5,6,7,-trinor-4,8-inter-m-phenylene 2-nor PGI2 derivatives and anti-ulcer, anti-thrombotic and anti-hypertensive pharmaceutical compositions containing them |
04/18/1989 | US4822802 Method of fentanly administration for postoperative pain relief |
04/18/1989 | US4822801 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents |
04/18/1989 | US4822799 Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals |
04/18/1989 | US4822798 Circulation-active 4-phenyl-6-substituted dihydropyrimidines |
04/18/1989 | US4822797 Piperazinyl carbonyl phenyl pyridazinone derivatives useful as cardiotonics |
04/18/1989 | US4822796 Analgesic, psychological disorders |
04/18/1989 | US4822794 Pyridooxazinone-pyridone compounds, cardiotonic compositions including the same, and their uses |
04/18/1989 | US4822793 And synthetic intermediates |
04/18/1989 | US4822792 Cardiovascular disroders |
04/18/1989 | US4822790 Antimicrobiocides or beta-lactamase inhibitors |
04/18/1989 | US4822789 Administering 2(4-methoxyphenyl)-3-acetoxy-5- 2(dimethylamino) ethyl!-8-chloro-2,3-dyhydro-1,5-benzothiazepin-(5h)-one |
04/18/1989 | US4822787 3-pyrrolidinylthio-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid compounds and antimicrobial activity thereof |
04/18/1989 | US4822785 Stabilized lactose, sodium chloride, lactose-sodium chloride aqueous solutions |